Clopidogrel Hypersensitivity: Pathogenesis, Presentation and Diagnosis

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Clopidogrel is an antiplatelet medication commonly prescribed to prevent thrombotic events.
• Hypersensitivity reactions to clopidogrel can occur, necessitating an understanding of their mechanisms and clinical manifestations.

Purpose of the Study:

• To provide a comprehensive overview of clopidogrel hypersensitivity.
• To elucidate the pathogenesis, clinical presentation, and diagnostic approaches for clopidogrel hypersensitivity.

Main Methods:

• Review of existing literature on clopidogogrel hypersensitivity.
• Analysis of case reports and clinical studies detailing T cell-mediated mechanisms.
• Evaluation of diagnostic tools such as patch testing and drug reintroduction.

Main Results:

• The majority of clopidogrel hypersensitivity cases involve a T cell-mediated, Gell and Coombs Type IV reaction.
• Common presentation includes a mild, delayed maculopapular erythematous rash 5-10 days post-initiation.
• Severe cutaneous, systemic, or immediate reactions are infrequent.

Conclusions:

• Clopidogrel hypersensitivity is predominantly a Type IV hypersensitivity reaction.
• Mild reactions may not necessitate drug discontinuation and can be diagnosed via clinical history or patch testing.
• Accurate diagnosis and understanding of pathogenesis are crucial for patient management.